JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Internal Medicine Section DOI : 10.7860/JCDR/2021/45792.14881
Year : 2021 | Month : May | Volume : 15 | Issue : 05 Full Version Page : OC11 - OC14

Echocardiographic Assessment of Cardiac Function in Liver Cirrhosis: A Cross-sectional Study

Apoorva Nirmal1, Gajendra Agrawal2, Sunil Kumar3, Sourya Acharya4, Akshay Dafal5, Dwivedi Bhushan6

1 Senior Resident, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Science (Deemed to be University), Wardha, Maharashtra, India.
2 Professor, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Science (Deemed to be University), Wardha, Maharashtra, India.
3 Professor, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Science (Deemed to be University), Wardha, Maharashtra, India.
4 Professor, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Science (Deemed to be University), Wardha, Maharashtra, India.
5 Senior Resident, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Science (Deemed to be University), Wardha, Maharashtra, India.
6 Professor, Department of Orthopaedics, Pataliputra Medical College and Hospital, Dhanbad, Jharkhand, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Sunil Kumar, Professor, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Science (Deemed to be University), Wardha, Maharashtra, India.
E-mail: sunilkumarmed@gmail.com
Abstract

Introduction

Echocardiography is a non invasive method to assess the cardiac dysfunction in liver cirrhosis. Early detection of cardiac dysfunction helps prevent morbidity in patients undergoing haemodynamics altering procedures like liver transplant or Transjugular Intrahepatic Portosystemic Shunt (TIPSS) or those who have haematemesis.

Aim

This study had been planned to assess the cardiac dysfunction and its incidence among patients of liver cirrhosis.

Materials and Methods

In this cross-divtional study total of 150 individuals with liver cirrhosis were enrolled and cardiac assessment was done in the form of systolic and diastolic dysfunction by 2D Echocardiography. It was correlated with the aetiology and severity of liver cirrhosis was assessed by Child Pugh’s criteria. The grading of diastolic dysfunction was done on the basis of Early/Late (E/A) Left Ventricular (LV) filling ratio as Grade I (Impaired relaxation pattern) E/A<0.8, Grade II (Pseudo normal) as E/A 0.8-1.5, and Grade III (Restrictive filling) E/A >2. Statistical analysis was done by using Chi-square test and Pearson’s Correlation Coefficient and p<0.05 is considered as level of significance.

Results

Out of the 150 patients of liver cirrhosis, cardiac dysfunction was noted in 51. Among 93 (62%) patients who had alcoholic aetiology, 4 (44.4%) had systolic dysfunction whereas 29 (69.0%) had diastolic dysfunction. Among 9 patients of Left Ventricular (LV) systolic dysfunction 2 (22.2%) patients were in grade A Child Pugh, 4 (44.4%) in grade B and 3 (33.4%) in grade C, all being statically significant (r=0.195; p=0.017). LV diastolic dysfunction was seen in 17 (20.2%) of Grade A, 14 (25%) of Grade B and 11 (100%) of Grade C of Child Pugh Score, all being statistically significant and well correlated according to severity (r=0.199; p=0.004).

Conclusion

The cardiac dysfunction was directly correlated with severity of liver cirrhosis according to Child Pugh scoring criteria thereby suggesting that possible cardiac changes were due to cirrhosis and not alcohol.

Keywords

Introduction

A hyperdynamic state in patients with cirrhosis is characterised by increased Cardiac Output (CO), plasma volume as well as a decreased Systemic Vascular Resistance (SVR) and blood pressure [1]. Initially, the impaired LV performance in cirrhotic patients was thought to be due to the direct toxic effect of alcohol [2].

Cirrhotic cardiomyopathy is the term used to describe a combination of symptoms suggestive of structural and functional cardiac changes resulting from liver cirrhosis. These encompass problems in systolic and diastolic dysfunction, electrophysiological changes and macroscopic and microscopic structural abnormalities. Alcoholic cardiomyopathy is a subtype of acquired dilated cardiomyopathy occurring as a result of high alcohol intake over a period of time. Hepatic cirrhosis culminates into hyperdynamic circulation, which leads to dysfunctions of cardiac structure and function that make up the Cirrhotic Cardiomyopathy (CCM) syndrome. This syndrome contains along with hyperdynamic circulation, systolic and diastolic dysfunctions, increased repolarisation of the ventricles, and problems with the sinus node in raising Heart Rate (HR) during increased activity [3-9].

Cardiac dysfunction in cirrhotic population occurs in the setting of a circulatory dysfunction and is characterised by dilated splanchnic vasculature. At the earlier stages of cirrhosis, the circulatory dysfunction is compensated by a hyperdynamic circulation. Later, the progression of liver disease and portal hypertension leads to progressive vasodilatation, which causes a decrease in the effective arterial blood volume that activates the Renin-Angiotensin-Aldosterone System (RAAS) and the Sympathetic Nervous System (SNS) [10]. These changes in the circulation can result in the cardiac dilatation of the left chambers and the beginning of functional cardiac changes. High norepinephrine levels cause impairment of β-adrenergic receptor function [11]. Factors apart from the sympathetic nervous activity and the aldosterone system have been suspected in the causation of cardiac dysfunction in cirrhosis. These are Nitric Oxide (NO), Carbon Monoxide (CMO) and endogenous cannabinoids [6]. Aggregation of these chemicals along the porto-systemic shunts may result in negative inotropic effect and these can also be involved in the pathogenesis of Left Ventricular Diastolic Dysfunction (LVDD) in Cardiomyopathy (CCM) [12]. Inflammation is implicated in the genesis of cardiac dysfunction particularly in decompensated cirrhosis. Cytokines can affect myocardial function in two ways, namely via the effects on both the myocyte contractility and the extracellular matrix [13] not only do they affect myocardial remodeling, but also the cytokines have been seen to have direct and indirect effects on myocardial function.

It has been estimated that as many as 50% of patients undergoing liver transplantation developed some signs of cardiac dysfunction and about 7-21% of patients died from heart failure in the post liver transplantation period [7,14]. Hence, this study was conducted to assess the occurrence of cardiac dysfunction in cirrhosis and to correlate with severity and aetiology of cirrhosis in our centre.

Materials and Methods

This cross-sectional study was conducted at Jawaharlal Nehru Medical College, Wardha, Maharashtra from September 2017 to September 2019. The approval from Institutional Ethics Committee was received on 30/09/2017 with Reference Number-DMIMS (DU)/IEC/2017-18/6754.

Sample size calculation: A total of 150 patients were enrolled according to sample size calculated with the following formula as N=Z 1-α/2*p* (1-p)/d2*; Where Zα/2=normal distribution at α/2=1.96; p=prevalence of cardiomyopathy in liver cirrhosis as per study of Somani PO et al., i.e., 30% [13]; d=desired margin of error 7%=0.07; n=1.962×0.30(1-0.30)=144.6. Patients presented to the hospital with complains suggestive of a presumptive diagnosis of liver cirrhosis (abdominal distension, pedal oedema, jaundice, altered sensorium) and were then diagnosed on the basis of clinical examination, laboratory parameters and ultrasonography findings.

Inclusion criteria: The cases included cirrhotic patients either with or without ascites, diagnosis of cirrhosis was made on unequivocal clinical grounds (chronic liver disease stigmata, jaundice, ascites, oesophageal varices), deranged liver function tests and ultrasonographic features consistent with cirrhosis (diffuse alteration and nodular transformation of liver parenchyma and signs of portal hypertension). Flow chart of the study had been shown in [Table/Fig-1].

Flow chart showing the plan of study.

USG: Ultrasonography; CTP: Child-turcotte pugh

Exclusion criteria: The exclusion criteria were cases of documented pre-existing cardiac dysfunction or history of cardiovascular disorder in the past, cases of existing pulmonary disease, with a smoking history, all patients under 18 years of age and patients with known anaemia, hypertension, cardiac, endocrine and renal disease leading to cardiac dysfunction.

Diagnosed cases of liver cirrhosis were considered after taking informed consent, history of alcoholism established using CAGE criteria [15], classified into Child Pugh Score A, B, C [16] followed by a detailed echocardiographic assessment of each case for LV systolic and diastolic dysfunction. Echocardiographic examinations was done using 2-Dimensional and Doppler Echocardiographic techniques using the Wipro Echocardiography Machine, (Wipro GE VIVIDE SR- 460051 WXE [15]) with patient lying in the supine and left decubitus position.

Systolic dysfunction: Thus, Ejection Fraction was calculated using SIMPSON’S formula

LVEF (%)=(Left Ventricle End Systolic Volume (LVEDV)-Left Ventricle End Systolic Volume (LVESV)÷LVEDV

Reference normal value used=An EF of <55% was taken as systolic dysfunction. Normal Left Ventricular Ejection Fraction (LVEF) >55% [16]

Diastolic dysfunction: Diastolic function can be assessed by multiple parameters (e.g., E/E’, E/A, Isovolumic Relaxation Time (IVRT), E-Wave Deceleration Time (EDT), Pulmonary Flow). No single parameter is perfect or superior over another. So, a combination approach was taken and hence parameter E/e’ and E/A were taken for this study.

Four chamber views was obtained and optimised. LV diastolic function was assessed by Doppler interrogation of Trans mitral velocity at early (E) and late (A) LV filling. From the mitral inflow signal, we measured the E velocity (E), the A velocity (A) and the E/A ratio of early diastolic LV filling. Pulsed wave Tissue Doppler Imaging (TDI) was performed at the junction of the septal mitral annulus. Early diastolic velocities (e’ medial) were recorded and E/e’ medial ratio was calculated and patient were categorised as Presence or Absence of LV diastolic dysfunction according to the American Society of Echocardiography (ASE) guidelines [17]. LVDD was said to be present if E/A ratio (cm/second) was between 0.8-1.5, and septal e’ was <8 cm/second. It was said to be absent if E/A ratio was more than 1 and septal e’ more than 8 cm/second.

The grades of diastolic dysfunction were defined on the basis of E/A ratio as Grade I (impaired relaxation pattern) E/A <0.8, Grade II (Pseudo normal) as E/A 0.8-1.5, and Grade III (Restrictive filling) E/A >2. To distinguish between Normal and Pseudo normal patterns, authors take normal as E/A ratio more than 1 but less than 2, both decreasing with Valsalva, and no change in ratio, and E/septal e’ less than 10, whereas Pseudo normal has E/A ratio of 0.8-1.5, on Valsalva E decreases more than A and ratio decreases <1 and E/septal e’ is more than 1 [18].

Statistical Analysis

This was done by using descriptive and inferential statistics using Chi-square test, Pearson’s Correlation Coefficient and Multiple Regression analysis and software used in the analysis was Statistical Package for the Social Science (SPSS) 22.0, and p<0.05 was considered as level of significance.

Results

Out of 150 patients, mean age and duration of hospital stay (days) amongst study population was 45.15±13.41 years and 5.32±2.08 days, respectively. About 62% of the study population were alcoholics. Cardiac dysfunction was noted in 51 (LVSD in 9 patients and LVDD in 42 patients). LV diastolic dysfunction was observed in 28% of study population and systolic dysfunction in 6% of the population. Out of 42 patients, 24 had Grade I Diastolic dysfunction 10 had Grade II Diastolic dysfunction and 8 had Grade III Diastolic dysfunction. All other baseline characteristics are shown in [Table/Fig-2].

Baseline characteristics of the study population n=150.

CharacteristicsValues
Mean age (years) (Mean±SD)45.15±13.41
Males, n (%)133 (88.7)
Females, n (%)17 (11.3)
Mean duration of stay at the hospital (days) (Mean±SD)5.32±2.08
Mean pulse rate (bpm) (Mean±SD)80.88±5.4
Mean blood pressure (mmHg) (Mean±SD)110/70±20/7.1
Number of patients who had a history of alcoholism, n (%)93 (62)
Number of patients who had no history of alcoholism, n (%)57 (38)
Echocardiographic parameters
LV ejection fraction (%) (Mean±SD)58.02±6.77
E/A ratio0.99-0.35
E/e’12.2-4.1
Cases having LVSD, n (%)9 (6)
Cases having LVDD American Society of Echocardiography (ASE) grading [17], n (%)42 (28)
Grade I24
Grade II10
Grade III8
Cases in CTP
CTP grade A84
CTP grade B55
CTP grade C11

LV: Left ventricler; LVSD: Left ventricular systolic dysfunction; LVDD: Left ventricular diastolic dysfunction; CTP: Child-turcotte-pugh


Among the 9 (6%) of patients having LVSD four was alcoholic and five non-alcoholic and this result had no statistically significant difference. Diastolic dysfunction was present in 69% of alcoholic patients and 31% of non-alcoholic patients with no statistically significant difference as shown in [Table/Fig-3].

Correlation of cardiac dysfunction with the aetiology of liver cirrhosis amongst study population.

VariablesAlcoholicNon-alcoholicTotal
Left ventricular systolic dysfunction (EF<55%)
Present4 (44.4%)5 (55.6%)9 (100%)
Absent89 (63.1%)52 (36.9%)141 (100%)
Total93 (62%)57 (38%)150 (100%)
  r=0.069    p=0.263
Left ventricular diastolic dysfunction
Present29 (69.0%)13 (31.0%)42 (100%)
Absent64 (59.3%)44 (40.7%)108 (100%)
Total93 (62%)57 (38%)150 (100%)
  r=0.079    p=0.334

(Pearson’s Correlation Coefficient and p-value were used for statistical analysis)

EF: Ejection fraction


Out of the 9 cirrhotic patients with LVSD two patients were in grade A CTP, four in grade B CTP and three in grade C CTP and this was statistically significant as per Chi-square test. LV Diastolic dysfunction was in 17 (20.2%) of Grade A of Child Pugh Score, 14 (25%) of Grade B and 11 (100%) Grade C with statistically significant difference as shown in [Table/Fig-4].

Correlation of cardiac dysfunction with the severity of liver cirrhosis amongst study population.

VariablesCTP ACTP BCTP CTotal
Left ventricular systolic dysfunction (EF <55%)
Present2 (22.2%)4 (44.4%)3 (33.4%)9 (100%)
Absent82 (58.2%)51 (36.2%)8 (5.6%)141 (100%)
Total84 (56%)55 (36.7%)11 (7.3%)150 (100%)
    r=0.195  p=0.017
Left ventricular diastolic dysfunction
Present17 (20.2%)14 (25%)11 (100%)42 (28%)
Absent67 (79.8%)41 (75%)0 (0%)108 (72%)
Total84 (100%)55 (100%)11 (100%)150 (100%)
    r=0.199  p=0.004

(Pearson’s Correlation Coefficient and p-value were used for statistical analysis)


Logistic regression for the predictor of cardiac dysfunction in the form of systolic and diastolic dysfunction was statistically of no significant difference, as shown in [Table/Fig-5].

Logistic regression of the Left Ventricular (LV) Diastolic Dysfunction and Left Ventricular (LV) Systolic Dysfunction.

VariablesVariables in the equation
B (LVDD)B (LVSD)S.E. (LVDD)S.E. (LVSD)Sig. (LVDD)Sig. (LVSD)Exp(B) (LVDD)Exp(B) (LVSD)
Step 1aAge-0.022-0.0240.0150.0280.1340.4030.9781
Gender (Male)1.18018.6060.7979240.3540.1390.9983.255120409234
History of alcohol (present)0.92018.9550.4215228.2220.0290.9972.511170628242
Constant-1.654-38.6451.13710616.8950.1460.9970.1910.000

a. Variable(s) entered on step 1: age, gender A, history of alcohol.

B (coefficient for the constant); SE (standard error), Exp (B) exponentiation of the B coefficient; Sig. (significance level.)


Discussion

A total of 150 cases where the mean age was 45.15 years, with a male: female ratio of 8:1, out of which 62% population had a history of alcoholism. This study shows that 6% of the study population had systolic dysfunction which was similar to the study conducted by Punekar P and Thakur DK which also show 6% of the study population of 100 patients, which was similar in the pattern with Ashmawy MM et al., showing systolic dysfunction in 10% of the patients and Hammami R et al., which showed 17.5% patients with systolic dysfunction [20-22]. In the present study, diastolic dysfunction was observed in 28% of study population. The diastolic dysfunction observed in this study had no significant correlation with the aetiology of the liver cirrhosis, but the correlation of the dysfunction with the severity of the disease seen by Child Pugh Score was found to be statistically significant, especially in Child Pugh Score Grade C, where 100% of the cases had diastolic dysfunction. This finding was in agreement with the other various studies conducted globally [23,24]. Karagiannakis DS et al., also found 38% patients with diastolic dysfunction which was not associated with the severity of the disease [25]. Sampaio F and Pimenta J, and Rimbas RC et al., also found the diastolic dysfunction to be 44% and 47.8% [26,27].

On the contrary, Sidmal PS et al., conducted a similar study in the South Indian population where the diastolic dysfunction was seen to be 91.6% (31.6% mild and 60% moderate) but that might have been because their study population comprised of more cases of CTP class C patients (30 out of 60 cases) than this study [28]. Similar results were seen with Ashmawy MM et al., Hammami R et al., and Salari A et al., where the study population consisted of a higher number of Child Pugh C patients than our study [21,22,29].

However, in our study, logistic regression for predictors of systolic dysfunction like age, male sex and history of alcohol consumption were found to be of no statistically significant difference, suggesting that the above variables maybe confounders for cardiac dysfunction in liver cirrhosis. There was no significant correlation in our study regarding the LV systolic dysfunction or the LV diastolic dysfunction with aetiology of liver cirrhosis (alcoholic and non-alcoholic). Though, the direct effects of cirrhosis on the cardiac function has statistical significance in our study, the role of alcohol in the LVSD and LVDD could not be significantly established, which suggests that cardiac changes in alcoholic liver cirrhosis are more because of the pathophysiological effects of cirrhosis than as a result of alcohol. Other studies by Lee SS and Alexander J et al., also stated that cardiac changes were due to cirrhosis per se rather than alcohol [30,31].

In the present study, systolic dysfunction was present in Child Pugh Score B (44.4%) as compared to Child Pugh Score A (22.2%) and Child Pugh Score C (33.4%); whereas Diastolic dysfunction was in 20.2% in Grade A of Child Pugh Score, 25% in Grade B of Child Pugh Score and 100% Grade C of Child Pugh Score. By this analysis it could be suggested that the more severe the disease, the more diastolic dysfunction. This finding was consistent with other various studies by Punekar P and Thakur DK, Sidmal PS et al., and Lee SS which revealed diastolic dysfunction was found to be more in Child Pugh Score grade C as compared to Child Pugh Score grade B and Child Pugh Score grade A [20,28,30]. Ashmawy MM et al., showed 60 patients with diastolic dysfunction out of which 30 were in CPS grade C which is higher in frequency compared to our study [21]. This could have been because the study was conducted with 30 patients in each Child Pugh group.

It is recommended that all patients of liver cirrhosis should undergo echocardiographic evaluation for cardiac dysfunction so that morbidity and mortality after haemodynamics altering procedures like liver transplantation and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) can be prevented.

Limitation(s)

A higher sample size would have shown more statistically significant correlation between the disease and the aetiology or severity. Details of long standing disease and follow-up were not included in this study.

Conclusion(s)

This study revealed higher prevalence of LV diastolic dysfunction as compared to LV systolic dysfunction in cases of liver cirrhosis. The correlation of left sided cardiac dysfunction with the aetiology of liver cirrhosis (alcoholic vs non-alcoholic) was statistically insignificant. The correlation of cardiac dysfunction with severity of liver cirrhosis (CTP scoring) was statistically significant thereby suggesting that the cardiac changes may be due to cirrhosis rather than alcohol.

LV: Left ventricler; LVSD: Left ventricular systolic dysfunction; LVDD: Left ventricular diastolic dysfunction; CTP: Child-turcotte-pugh(Pearson’s Correlation Coefficient and p-value were used for statistical analysis)EF: Ejection fraction(Pearson’s Correlation Coefficient and p-value were used for statistical analysis)a. Variable(s) entered on step 1: age, gender A, history of alcohol.B (coefficient for the constant); SE (standard error), Exp (B) exponentiation of the B coefficient; Sig. (significance level.)

References

[1]Al-Hamoudi WK, Cardiovascular Changes in Cirrhosis: Pathogenesis and clinical implications Saudi J Gastroenterol 2010 16(3):145-53.10.4103/1319-3767.6518120616408  [Google Scholar]  [CrossRef]  [PubMed]

[2]Agrawal S, Sarode R, Kumar S, Study of left atrial enlargement and its correlation with left ventricular hypertrophy in patients with systemic hypertension Paripex- Indian Journal of Research 2018 7(2):82-84.  [Google Scholar]

[3]Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassel BW, Cirrhotic Cardiomyopathy J Am Coll Cardiol 2010 56:539-49.10.1016/j.jacc.2009.12.07520688208  [Google Scholar]  [CrossRef]  [PubMed]

[4]Cazzaniga M, Salerno F, Pagnossi G, Dionigi E, Visentin S, Cirelloo I, Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt Gut 2007 56:86-75.10.1136/gut.2006.10246717135305  [Google Scholar]  [CrossRef]  [PubMed]

[5]Moller S, Dumcke CW, Krag A, The heart and the liver Expert Rev Gastroenterol Hepatol 2009 3:51-64.10.1586/17474124.3.1.5119210113  [Google Scholar]  [CrossRef]  [PubMed]

[6]Wiese S, Hove JD, Bendtsen F, Moller S, Cirrhotic cardiomyopathy: Pathogenesis and clinical relevance Nat Rev Gastroenterol Hepatol 2014 11:177-86.10.1038/nrgastro.2013.21024217347  [Google Scholar]  [CrossRef]  [PubMed]

[7]Gassanov N, Caglayan E, Semmo N, Messenkeil G, Er F, Cirrhotic cardiomyopathy: A cardiologist’s perspective World J Gastroenterol 2014 20:15492-98.10.3748/wjg.v20.i42.1549225400434  [Google Scholar]  [CrossRef]  [PubMed]

[8]Bernardi M, Maggioli C, Dibra V, Zaccherini G, QT interval prolongation in the liver cirrhosis: Innocent by stander or serious threat? Expert Rev Gastroenterol Hepatol 2012 6:57-66.10.1586/egh.11.8622149582  [Google Scholar]  [CrossRef]  [PubMed]

[9]Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Moller S, Dyssynchronous electrical and mechanical systole in patients with cirrhosis J Hepatol 2002 36:513-20.10.1016/S0168-8278(02)00010-7  [Google Scholar]  [CrossRef]

[10]Arroyo V, Terra C, Ruiz-del-Arbol L, Pathogenesis, diagnosis and treatment of ascites in cirrhosis. Rodés J, Benhamou JP, Blei AT, Reichen J, Rizzetto M, editors Textbook of Hepatology: From Basic Science to Clinical Practice 2008 3rd edOxfordBlackwell Publishing Ltd:666-710.10.1002/9780470691861.ch7e  [Google Scholar]  [CrossRef]

[11]Agrawal S, Kumar S, Gabhane V, Acharya S, Wanjari A, Electrocardiography and echocardiography correlation in patients of left ventricular hypertrophy Journal of Clinical & Diagnostic Research 2019 13(12):OC01-04.10.7860/JCDR/2019/42697.13329  [Google Scholar]  [CrossRef]

[12]De BK, Majumdar D, Das D, Biswas PK, Mandal SK, Ray S, Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis J Hepatol 2003 39:315-19.10.1016/S0168-8278(03)00271-X  [Google Scholar]  [CrossRef]

[13]Somani PO, Contractor Q, Chaurasia AS, Rathi PM, Diastolic dysfunction characterises cirrhotic cardiomyopathy Indian Heart J 2014 66:649-55.10.1016/j.ihj.2014.06.00125634400  [Google Scholar]  [CrossRef]  [PubMed]

[14]Prabhu SD, Cytokine-induced modulation of cardiac function Circ Res 2004 95:1140-53.10.1161/01.RES.0000150734.79804.9215591236  [Google Scholar]  [CrossRef]  [PubMed]

[15]Myers RP, Lee SS, Cirrhotic cardiomyopathy and liver transplantation Liver Transpl 2000 :S44-52.10.1002/lt.50006051010915191  [Google Scholar]  [CrossRef]  [PubMed]

[16]Durand F, Valla D, Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD J Hepatol 2005 42(1):S100-07.10.1016/j.jhep.2004.11.01515777564  [Google Scholar]  [CrossRef]  [PubMed]

[17]Armstrong WF, Ryan T, Feigenbaum’s Echocardiography 2012 Eighth editionPhiladelphiaLippincott Williams & Wilkins:128-36.  [Google Scholar]

[18]Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 2009 22(2):107-33.10.1016/j.echo.2008.11.02319187853  [Google Scholar]  [CrossRef]  [PubMed]

[19]Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: A report From the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography J Am Soc Echocardiogr 2009 22(9):975-1014.10.1016/j.echo.2009.07.01319733789  [Google Scholar]  [CrossRef]  [PubMed]

[20]Punekar P, Thakur DK, Echocardiographic changes in chronic liver disease International Journal of Contemporary Medical Research 2018 5(3):C01-04.  [Google Scholar]

[21]Ashmawy MM, Younis HA, Elbaset MA, Rahman HA, Ashmawy AM, Shawky MA, Evaluation of cardiac function in patients with liver cirrhosis using tissue Doppler study The Egyptian Journal of Internal Medicine 2018 30(3):11510.4103/ejim.ejim_28_18  [Google Scholar]  [CrossRef]

[22]Hammami R, Boudabbous M, Jdidi J, Trabelsi F, Mroua F, Kallel R, Cirrhotic cardiomyopathy: Is there any correlation between the stage of cardiac impairment and the severity of liver disease? Libyan J Med 2017 12:128-32.10.1080/19932820.2017.128316228245727  [Google Scholar]  [CrossRef]  [PubMed]

[23]Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Ginès P, Moreira V, Circulatory function and hepatorenal syndrome in cirrhosis Hepatology 2005 42(2):439-47.10.1002/hep.2076615977202  [Google Scholar]  [CrossRef]  [PubMed]

[24]Anish PG, Jayaprasad N, Madhavan S, George R, Echocardiographic abnormalities in patients with cirrhosis and relation to disease severity Heart India 2019 7:26-30.10.4103/heartindia.heartindia_37_18  [Google Scholar]  [CrossRef]

[25]Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD, Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis Hepatol Int 2014 8:588-94.10.1007/s12072-014-9544-626202764  [Google Scholar]  [CrossRef]  [PubMed]

[26]Sampaio F, Pimenta J, Left ventricular function assessment in cirrhosis: Current methods and future directions World J Gastroenterol 2016 22:112-25.10.3748/wjg.v22.i1.11226755864  [Google Scholar]  [CrossRef]  [PubMed]

[27]Rimbas RC, Baldea SM, Guerra R, Visoiu SI, Rimbas M, Pop CS, New definition criteria of myocardial dysfunction in patients with liver cirrhosis: A speckle tracking and tissue doppler imaging study Ultrasound Med Biol 2018 44:562-74.10.1016/j.ultrasmedbio.2017.11.01329306590  [Google Scholar]  [CrossRef]  [PubMed]

[28]Sidmal PS, Prashanthkumar BG, Shekarappa KC, Pattern of diastolic dysfunction in alcoholic and nonalcoholic cirrhotic portal hypertensive patients with or without ascites in rural population in South India Int J Res Med Sci 2015 3:2316-22.10.18203/2320-6012.ijrms20150623  [Google Scholar]  [CrossRef]

[29]Salari A, Shafaghi A, Ofoghi M, Saeidinia A, Mansour-Ghanaei F, Diastolic dysfunction and severity of cirrhosis in nonalcoholic cirrhotic patients Int J Hepatol 2013 2013:892-98.10.1155/2013/89287624377048  [Google Scholar]  [CrossRef]  [PubMed]

[30]Lee SS, Cardiac abnormalities in liver cirrhosis West J Med 1989 151(5):530-35.  [Google Scholar]

[31]Alexander J, Mishra P, Desai N, Ambadekar S, Gala B, Sawant P, Cirrhotic cardiomyopathy: Indian scenario Journal of Gastroenterology and Hepatology 2007 22(3):395-99.10.1111/j.1440-1746.2006.04507.x17295773  [Google Scholar]  [CrossRef]  [PubMed]